Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray ... acetonide nasal aerosol spray and fluticasone propionate aqueous solution spray in the ...
Hikma will continue producing its 8 mg naloxone HCl nasal spray in its Columbus, Ohio manufacturing facility and will provide it to Emergent as its exclusive commercial partner. "We are thrilled ...
The United St a tes Food and Drug Administration (USFDA) has warned health care professionals not to use unapproved epinephrine nasal solutions. According to a statement issued by the federal ...
Under the terms of the six-year agreement, Emergent will add KLOXXADO® Nasal Spray to its naloxone product portfolio and will be responsible for all North America product sales and marketing. Hikma ...
Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent's ability to distribute multiple life-saving opioid overdose ...
About NARCAN ® Nasal Spray NARCAN ® Naloxone HCl Nasal Spray 4 mg is the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product for the emergency treatment of opioid overdose.
(RTTNews) - Hikma Pharmaceuticals plc (HIK, HIK.L) announced Tuesday that it has entered an exclusive commercial partnership with Emergent BioSolutions for the sale of KLOXXADO naloxone HCl nasal ...
on Tuesday announced that it has entered into an agreement to obtain exclusive commercial rights in the U.S. and Canada for KLOXXADO or naloxone HCl Nasal Spray from Hikma Pharmaceuticals.